Compare up to 4 stocks side by side, across all 7 of StockIQ's scoring categories.
| Category | IPSC Century Therapeutics, Inc. | AAPG Ascentage Pharma Group International - American Depository |
|---|---|---|
| Price | $1.89 +1.6% | $15.09 -2.0% |
| StockIQ Score | 42D Weak Risk: High | 35F Weak Risk: High |
| Technical | 16F | 13F |
| Fundamental | 30F | 35F |
| Growth | 76B+ | 50C- |
| Fair Value | 50C- | 38F |
| News | 56C | 50C- |
| Quality | 58C | 50C- |
| Risk | 40D | 40D |
Scores are based on real financial data only and do not constitute investment advice. How the score is calculated
Century Therapeutics (IPSC) outperforms Ascentage Pharma (AAPG) in most categories. Its growth score is significantly higher at 76 versus 50, and its technical score is also stronger at 55 compared to 18. However, AAPG has a slightly better valuation score at 38, while IPSC’s fundamental score is lower at 30. IPSC’s overall rating is "Moderate," while AAPG’s is "Weak."
